Share Twitter LinkedIn Facebook Email Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Xofigo Program. At ESMO Oncology Conference – Munich, Germany On October 19, 2018. Advertisement
Alcohol Consumption and Cancer Risk: Insights from the 2025 Surgeon General’s Advisory Breast Cancer 3 Mins Read